Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Eight-Year Outcomes Following ABO-Incompatible Kidney Transplantation Performed after Desensitization by Antigen-Unspecific Immunoadsorption Devices
C. Speer¹, F. Kälble¹, L. Pego da Silva¹, C. Nusshag¹, M. Schaier¹, C. Süsal², C. Sommerer¹, M. Zeier¹, C. Morath¹
¹Nephrology, University of Heidelberg, Heidelberg, Germany, ²Immunology, University of Heidelberg, Heidelberg, Germany
*Purpose: Owing to the unmet need of available kidney grafts, ABO-incompatible kidney transplantation (KTX) has been established to enlarge the possible donor pool. The current…
2019 American Transplant Congress
Brief Normothermic Machine Perfusion is Superior to Cold Storage Alone – A Paired Discarded Human Kidney Analysis
A. Hameed¹, E. Patrick², D. B. Lu¹, C. P'ng¹, M. Hu², Y. Chew², R. De Roo¹, L. Yuen¹, W. Hawthorne¹, N. Rogers¹, H. Pleass¹
¹Westmead Hospital, Sydney, Australia, ²Westmead Institute for Medical Research, Sydney, Australia
*Purpose: The use of marginal has increased due to ongoing donor shortages. These kidneys have higher rates of graft discard after procurement, and also have…
2019 American Transplant Congress
Recurrent Diabetic Nephropathy Despite Intensive Glycemic Control: An Observational Cohort Study
M. Coemans, E. Van Loon, E. Lerut, D. Kuypers, B. Sprangers, P. Gillard, C. Mathieu, G. Verbeke, M. Naesens
KU Leuven, Leuven, Belgium
*Purpose: After kidney transplantation, recurrence of diabetic nephropathy has been reported. The presentation and kinetics of recurrent diabetic nephropathy and its risk factors remain however…
2019 American Transplant Congress
Vaccination Rates and Relation to Health Beliefs in Inner-City Kidney Transplant Recipients (KTRs)
Y. Akivis, J. Leong, I. Rosenstein, A. Myrie, M. Moy, M. Markell
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Prophylaxis against viral and bacterial infections as outlined by guidelines issued by the 2013 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for…
2019 American Transplant Congress
Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation
J. M. Rohan¹, J. P. Leone², E. S. Woodle³, D. Kaufman⁴, A. R. Shields³, A. Wiseman⁵, A. J. Matas⁶, P. West-Thielke⁷, E. King³, R. R. Alloway³
¹Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, ²Tampa General Hospital, Tampa, FL, ³University of Cincinnati College of Medicine, Cincinnati, OH, ⁴University of Wisconsin – Madison, Madison, WI, ⁵University of Colorado - Denver, Denver, CO, ⁶University of Minnesota Medical Center, Minneapolis, MN, ⁷University of Illinois – Chicago, Chicago, IL
*Purpose: Previous trials have not examined differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx) patients (pts).…
2019 American Transplant Congress
Association of Pretransplant and Posttransplant 5-Tier Ratings with Candidate Mortality after Listing
A. Wey, S. Gustafson, N. Salkowski, B. Kasiske, M. Skeans, C. Schaffhausen, A. Israni, J. Snyder
SRTR, Minneapolis, MN
*Purpose: The OPTN Final Rule mandates the Scientific Registry of Transplant Recipients (SRTR) to publish understandable reports of transplant rate, waitlist mortality, and posttransplant outcomes.…
2019 American Transplant Congress
6-Minute Walk Testing in Patients on the Kidney Transplant Waitlist
X. S. Cheng¹, J. Lee², K. V. Discipulo¹, J. Myers³, J. C. Tan¹
¹Nephrology, Stanford University, Palo Alto, CA, ²Kidney Transplant, Stanford Hospital, Palo Alto, CA, ³Cardiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA
*Purpose: Poor physical function in kidney transplant candidates is associated with frailty, sub-optimal transplant outcomes, and higher health care utilization. We need an instrument to…
2019 American Transplant Congress
Advanced Immunological T-cell Ageing Defined by a Very Low Thymic Function Identifies Patients with a Substantial Increased Risk for Long-Term Mortality after Kidney Transplantation
M. G. Betjes, A. Langerak, M. Klepper, N. Litjens
Nephrology & Transplantation, Erasmus MC, Rotterdam, Netherlands
*Purpose: End-stage renal disease is associated with premature ageing of the T-cell immune system. At the time of kidney transplantation the average biological age of…
2019 American Transplant Congress
Unos Analysis Of Deceased Donor Renal Transplant (ddrtx) Outcomes In Sensitized Patients After Implementation Of The Kidney Allocation System (kas)
R. J. Crew, K. L. King, M. Fajardo, J. Hedvat, N. Lange, S. Husain, S. Mohan, L. E. Ratner, S. S. Patel
Columbia University Irving Medical Center, New York, NY
*Purpose: Introduction of KAS in 2014 prioritized access to DDRTx for highly-sensitized candidates although it was unclear whether the outcomes would be acceptable in this…
2019 American Transplant Congress
Economic Impact of Donor Hepatitis C Kidney Transplantation: A Medicare Cost Analysis
K. Lentine¹, M. Schnitzler², T. Alhamad³, H. Xiao², H. Randall², J. Wellen², B. Kasiske⁴, G. Hess⁵, D. Axelrod⁶
¹Saint Louis University Medical Center, St. Louis, MO, ²Saint Louis Univ, St. Louis, MO, ³Washington Univ, St. Louis, MO, ⁴SRTR, Minneapolis, MN, ⁵Univ of Pennsylvania, Philadelphia, PA, ⁶Univ of Iowa, Iowa City, IA
*Purpose: In the era of highly effective direct-acting antiviral agents (DAAs), kidney transplant (KT) from Hepatitis C virus (HCV)-positive donors is increasingly considered as an…